Yayın:
Insulin analogue usage in a haemodialysis patient with type 2 diabetes mellitus

Basit Görünüm
dc.contributor.buuauthorErsoy, Alpaslan
dc.contributor.buuauthorErsoy, Canan
dc.contributor.buuauthorAltınay, Tumay
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentEndokrinoloji ve Metabolizma Bölümü
dc.contributor.departmentNefroloji ve Diyaliz Ana Bilim Dalı
dc.contributor.orcid0000-0002-0710-0923
dc.contributor.researcheridAAH-8861-2021
dc.contributor.researcheridAAH-5054-2021
dc.contributor.scopusid35612977100
dc.contributor.scopusid6701485882
dc.contributor.scopusid12040285800
dc.date.accessioned2021-11-22T13:19:09Z
dc.date.available2021-11-22T13:19:09Z
dc.date.issued2006
dc.identifier.citationErsoy, A. vd. (2006). ''Insulin analogue usage in a haemodialysis patient with type 2 diabetes mellitus''. Nephrology Dialysis Transplantation, 21(2), 553-554.
dc.identifier.doi10.1093/ndt/gfi205
dc.identifier.endpage554
dc.identifier.issn0931-0509
dc.identifier.issue2
dc.identifier.pubmed16221693
dc.identifier.scopus2-s2.0-31544464630
dc.identifier.startpage553
dc.identifier.urihttps://doi.org/10.1093/ndt/gfi205
dc.identifier.urihttps://academic.oup.com/ndt/article/21/2/553/1850702
dc.identifier.urihttp://hdl.handle.net/11452/22762
dc.identifier.volume21
dc.identifier.wos000234782900057
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherOxford Univ Press
dc.relation.journalNephrology Dialysis Transplantation
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectTransplantation
dc.subjectUrology & nephrology
dc.subjectTherapy
dc.subject.emtreeLong acting drug
dc.subject.emtreeIsophane insulin
dc.subject.emtreeInsulin lispro
dc.subject.emtreeInsulin glargine
dc.subject.emtreeInsulin derivative
dc.subject.emtreeHemoglobin A1c
dc.subject.emtreePriority journal
dc.subject.emtreeNon insulin dependent diabetes mellitus
dc.subject.emtreeLetter
dc.subject.emtreeKidney failure
dc.subject.emtreeInsulin treatment
dc.subject.emtreeHypoglycemia
dc.subject.emtreeHyperinsulinemia
dc.subject.emtreeHuman
dc.subject.emtreeHemodialysis
dc.subject.emtreeGlucose homeostasis
dc.subject.emtreeFemale
dc.subject.emtreeDrug dose regimen
dc.subject.emtreeDrug cost
dc.subject.emtreeClinical feature
dc.subject.emtreeCase report
dc.subject.emtreeAdult
dc.subject.meshRenal dialysis
dc.subject.meshMiddle aged
dc.subject.meshDiabetes mellitus, type 2
dc.subject.meshFailure, chronic
dc.subject.meshKidney
dc.subject.meshInsulin
dc.subject.meshHypoglycemic agents
dc.subject.meshHumans
dc.subject.meshFemale
dc.subject.scopusGlycosylated Albumin; Peritoneal Dialysis; Hemodialysis
dc.subject.wosTransplantation
dc.subject.wosUrology & nephrology
dc.titleInsulin analogue usage in a haemodialysis patient with type 2 diabetes mellitus
dc.typeArticle
dc.wos.quartileQ1 (Urology & nephrology)
dc.wos.quartileQ2 (Transplantation)
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Nefroloji ve Diyaliz Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/Endokrinoloji ve Metabolizma Bölümü
local.indexed.atScopus
local.indexed.atWOS

Dosyalar

Lisanslı seri

Şimdi gösteriliyor 1 - 1 / 1
Placeholder
Ad:
license.txt
Boyut:
1.71 KB
Format:
Item-specific license agreed upon to submission
Açıklama
İndir

Koleksiyonlar

İndeksli Yayınlar / Indexed Publications